Alira Health

Alira Health is an international advisory firm that specializes in providing integrated transaction advisory, management consulting, medical affairs advisory, and innovative research services for healthcare and life science companies. Founded in 1999 and headquartered in the United States, Alira Health collaborates with strategists, bankers, doctors, and scientists to deliver comprehensive insights across various facets of healthcare. The firm assists multinational corporations, institutional investors, creditors, and governments in activities such as company sales, acquisitions, strategic partnerships, and financial restructurings, aiming to enhance the efficiency and effectiveness of funding and operational strategies worldwide.

Gabriele Brambilla

Co-Owner and Co-CEO

Jean-Louis Simon

Partner

10 past transactions

Artisan Healthcare Consulting

Acquisition in 2022
Artisan Healthcare Consulting is a management consulting firm focused on the healthcare sector, offering a range of services designed to support business growth. The firm provides strategic and quantitative analysis, along with consultancy in business development, brand strategy, and analytics. Artisan Healthcare Consulting specializes in areas such as emerging biopharma, global market access, primary market research, and supply chain strategy. By leveraging its expertise, the firm aims to enhance market growth for healthcare companies, helping them navigate challenges and capitalize on opportunities within the industry.

Sourcia

Acquisition in 2022
Sourcia is a clinical trial services provider specializing in the biotechnology and medical device sectors. The company offers comprehensive support for clinical trials ranging from Phase I to Phase IV, including pre- and post-CE marking studies. Targeting small-to-medium-sized biotech and medical device companies in Europe, Sourcia provides drug development and consulting services aimed at facilitating the creation of new medical therapies. By focusing on these specific industries, Sourcia enables its clients to innovate and expand their capabilities throughout the development process.

Self Care Catalysts

Acquisition in 2022
Self Care Catalysts is a company that focuses on empowering patients through enhanced insights and data. Based in the MaRS Discovery District in Toronto and San Francisco, it has developed a cloud-based platform that supports digital therapeutics, patient informatics, and self-care. The platform is designed to facilitate patient-centered clinical trials, evaluate patient engagement, implement behavioral intervention programs, and provide analytics that aid patients, healthcare providers, and pharmaceutical companies. By delivering tailored health storylines, Self Care Catalysts enables users to make informed decisions that contribute to improved health outcomes.

PatchAi

Acquisition in 2021
PatchAi Srl is a startup focused on enhancing late-phase and real-world medical studies using artificial intelligence, machine learning, and natural language generation technologies. Their primary product, PatchAi, is a cognitive platform designed to improve patient engagement in clinical trials by employing an empathetic virtual assistant that collects data on symptoms, adverse events, therapy adherence, and quality of life. This platform aims to facilitate safer, faster, and more affordable medical product development, ultimately benefiting patients' lives.

Be Patient

Acquisition in 2021
Be Patient provides e-Health solutions for human care.

CROS NT

Acquisition in 2021
CROS NT is a provider of innovative biometrics solutions focused on enhancing the development of therapeutics for patients. The company specializes in data-driven services that include digital technologies, data integration, standardization, visualization, and analytics. By leveraging its expertise in clinical data management, biostatistics, and statistical programming, CROS NT aims to support clients in achieving improved insights and outcomes while reducing risks in their projects. Through its tailored approach, the company is committed to making the therapeutic development process more efficient and affordable.

X-COR Therapeutics

Seed Round in 2020
X-COR Therapeutics, Inc. is a medical device company based in Allston, Massachusetts, focused on developing innovative solutions for treating acute respiratory failure. Founded in 2017, the company has created a CO2 removal device that operates using ultra-low blood flows, which allows for a safer and more accessible treatment option compared to traditional extracorporeal devices that require higher flow rates and specialized medical personnel. X-COR's technology incorporates a novel consumable hybrid cartridge that efficiently removes excess CO2 from patients' blood through small catheters, enabling easier placement by nursing staff. The accompanying control algorithm utilizes machine-learning techniques to enhance the device's performance. This approach not only reduces the invasiveness of the procedure but also makes the therapy more affordable and practical for healthcare settings. X-COR Therapeutics aims to transform the management of symptomatic lung failure with its cutting-edge technology.

Wellmera

Acquisition in 2019
Wellmera AG is an independent consulting firm based in Basel, Switzerland, established in 2011. It specializes in providing a range of services, including market access, pricing, health economics and outcomes research (HEOR), and commercial expertise to pharmaceutical and biotechnology companies. The company focuses on helping clients demonstrate the value of their products, optimize patient access, and leverage commercial opportunities within the healthcare market. As of late 2019, Wellmera operates as a subsidiary of CMC Consulting Boston Inc., enhancing its capabilities in delivering tailored solutions to the industry.

Clinical Insights

Acquisition in 2018
Clinical Insights Limited, established in 2012, is a Milan-based company operating as a subsidiary of CMC Consulting Boston Inc. It specializes in providing data analytics and predictive analysis services tailored for healthcare companies, particularly pharmaceutical firms. The company's core offerings include tools and business advisory services that leverage sophisticated analyses of real-time big data to optimize performance, enhance market insights, and improve overall business efficiency. Clinical Insights Limited helps clients uncover hidden product flows, smooth out demand volatility, refine messaging strategies, and gain deeper insights into patient treatment patterns by embedding analytical techniques and proprietary market information into users' management systems. The company maintains offices in Coventry (UK), Milano (Italy), Athens (Greece), and San Gwann (Malta).
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.